CD73 disruption with tumor-specific CRISPR/Cas9 nanoparticles reduces adenosine-mediated immunosuppression and amplifies response to chemotherapy. (nature.com)

Authors: Sun X … Tay A Journal: Nature Communications Published: 2026-09-08 DOI: https://doi.org/10.1038/s41467-026-77547-4